Valuation: Oscotec Inc.

Market Cap 1,211B 903M 822M 757M 689M 1.29B 83.58B 1.36B 9.22B 3.66B 45.65B 3.39B 3.32B 143B P/E 2026 *
37.6x
P/E 2027 * 10.1x
Enterprise Value 1.03B 765K 696K 642K 584K 1.1M 70.81M 1.15M 7.81M 3.1M 38.68M 2.87M 2.81M 121M EV / Sales 2026 *
12.2x
EV / Sales 2027 * 4.72x
Free-Float
72.01%
Yield 2026 *
-
Yield 2027 * -
1 day-3.06%
1 week-11.59%
Current month-13.17%
1 month-16.27%
3 months-13.76%
6 months-18.95%
Current year-29.98%
1 week 31,400
Extreme 31400.00000000
36,700
1 month 31,400
Extreme 31400.00000000
39,450
Current year 27,300
Extreme 27300
60,200
1 year 27,300
Extreme 27300
66,000
3 years 18,000
Extreme 18000
66,000
5 years 15,850
Extreme 15850
66,000
10 years 5,630
Extreme 5630
71,500
Manager TitleAgeSince
Chief Executive Officer 64 26/03/2020
Corporate Officer/Principal 54 01/09/1999
Chief Tech/Sci/R&D Officer 63 -
Director TitleAgeSince
Director/Board Member 54 01/09/1999
Director/Board Member 64 26/03/2020
Director/Board Member 66 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
24/07/25 Buy 500 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-3.06%-11.59%-42.14%+61.56% 903M
-0.30%-6.68%+27.12%+127.32% 1,200B
+1.25%-5.35%+32.65%+78.98% 651B
+0.94%-2.99%+21.13%+106.30% 506B
-0.60%-1.95%+25.73%+67.00% 377B
+0.69%-9.50%+36.78%+30.83% 330B
+0.41%-4.70%+24.18%+50.18% 288B
+0.81%-4.08%-2.95%+31.59% 272B
-0.15%-6.45%+29.06%+65.76% 236B
-0.06%-0.98%+31.42%+122.83% 206B
Average -0.01%-5.04%+18.30%+74.24% 407B
Weighted average by Cap. +0.30%-5.19%+26.01%+87.87%

Financials

2026 *2027 *
Net sales 84B 62.61M 57.03M 52.55M 47.8M 89.68M 5.8B 94.25M 640M 254M 3.17B 235M 230M 9.94B 192B 143M 130M 120M 109M 205M 13.25B 215M 1.46B 581M 7.24B 537M 526M 22.72B
Net income 32B 23.85M 21.73M 20.02M 18.21M 34.16M 2.21B 35.9M 244M 96.84M 1.21B 89.5M 87.61M 3.79B 119B 88.7M 80.79M 74.44M 67.72M 127M 8.21B 134M 906M 360M 4.49B 333M 326M 14.08B
Net Debt -185B -138M -126M -116M -105M -197M -12.77B -208M -1.41B -560M -6.97B -517M -506M -21.89B -304B -227M -206M -190M -173M -325M -20.98B -341M -2.31B -920M -11.46B -850M -832M -35.97B
Projected Income Statement - Annual - Oscotec Inc.
Logo Oscotec Inc.
Oscotec Inc is a Korea‑based company primarily engaged in new drug development business. The Company operates four main businesses. The new drug development business primarily mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next‑generation solid tumor treatments designed to overcome drug resistance. The dental bone graft business primarily supplies bone graft materials. The dental barrier membrane business provides own developed absorbable collagen barrier membranes. The functional materials and related products business primarily provide functional materials for osteoporosis prevention and bone health, materials and finished products for arthritis prevention and alleviation, and functional materials for periodontal disease prevention and alleviation.
Employees
57
Date Price Change Volume
20/11/26 ₩31,650.00 -3.06% 73,039
19/11/26 ₩32,650.00 +1.08% 83,518
18/11/26 ₩32,300.00 -1.37% 121,015
17/11/26 ₩32,750.00 -4.38% 140,307
16/11/26 ₩34,250.00 -4.33% 94,979
Trader
Investor
-
Global
-
Quality
ESG MSCI
CCC
MarketScreener Ratings - Oscotec Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
31,650.00KRW
Average target price
75,000.00KRW
Spread / Average Target
+136.97%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Oscotec Inc.
  1. Stock Market
  2. Stocks
  3. A039200 Stock